These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22003538)

  • 1. FDA notifications. Intron label change approved by FDA.
    AIDS Alert; 2011 Sep; 26(9):107. PubMed ID: 22003538
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA notifications. Renal impairment addressed in labeling.
    AIDS Alert; 2011 Nov; 26(11):131. PubMed ID: 22164522
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment for hepatitis C OK'd.
    Posit Living; 2001 Feb; 10(2):10. PubMed ID: 11548492
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA notifications. Norvir label changes approved.
    AIDS Alert; 2008 Oct; 23(10):115-6. PubMed ID: 18938256
    [No Abstract]   [Full Text] [Related]  

  • 5. New advances in hepatitis C therapy.
    Proj Inf Perspect; 2000 Aug; (30):18-9. PubMed ID: 12171011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA notifications. Etravirine label updated by FDA.
    AIDS Alert; 2010 May; 25(5):59-60. PubMed ID: 20564814
    [No Abstract]   [Full Text] [Related]  

  • 7. Peginterferon alph-2b (Sylatron) for melanoma.
    Med Lett Drugs Ther; 2011 Sep; 53(1373):76. PubMed ID: 21921873
    [No Abstract]   [Full Text] [Related]  

  • 8. Spontaneous reports as evidence of adverse drug reactions.
    Singh S; Trivedi AN
    South Med J; 2008 Jan; 101(1):16. PubMed ID: 18176284
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA notifications. Darunavir label has these changes.
    AIDS Alert; 2008 Dec; 23(12):142-4. PubMed ID: 19112649
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA notifications. New risk information added to label of antiviral saquinavir.
    AIDS Alert; 2010 Dec; 25(12):143-4. PubMed ID: 21328816
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA notifications. Lopinavir/ritonavir label updated.
    AIDS Alert; 2008 Aug; 23(8):92. PubMed ID: 18727173
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA notifications. Kaletra revisions to packaging approved.
    AIDS Alert; 2010 Mar; 25(3):34. PubMed ID: 20629261
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA notifications. Agenerase product label changed.
    AIDS Alert; 2002 Oct; 17(10):131. PubMed ID: 12400469
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pegasys: FDA approved Pegasys (peginterferon alfa-2a) for the treatment of hepatitis C].
    Iafolla M
    Sidahora; 2002; (4):8-10. PubMed ID: 12703472
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA notifications. New labeling for N-9 products?
    AIDS Alert; 2003 Mar; 18(3):40. PubMed ID: 12635610
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA notifications. FDA revises Baraclude labeling for HIV patients.
    AIDS Alert; 2007 Sep; 22(9):103-4. PubMed ID: 18415955
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA notifications. Labeling changed on Prezista.
    AIDS Alert; 2010 Mar; 25(3):34-6. PubMed ID: 20632456
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA notifications. Entecavir (Baraclude®) labeling changed.
    AIDS Alert; 2010 Dec; 25(12):141-2. PubMed ID: 21328814
    [No Abstract]   [Full Text] [Related]  

  • 19. Hematologic side effects of PEG interferon and ribavirin. Management with growth factors.
    Keeffe EB; Kowdley KV
    J Clin Gastroenterol; 2005 Jan; 39(1 Suppl):S1-2. PubMed ID: 15597022
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA notifications. Updates made to Reyataz package insert.
    AIDS Alert; 2008 Oct; 23(10):116-7. PubMed ID: 18935687
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.